A Record Year and a 2026 Guide Whose Growth Is Mostly Arithmetic: Maintaining Hold on Lockheed Martin

Results vs. Consensus

Two consensus EPS figures were circulating into the print, $5.75 and $5.85, and the reported $5.80 landed between them. We treat the quarter's EPS as in line rather than claiming a beat or a miss, because the dispersion reflects genuine disagreement about whether and at what size analysts had modelled the pension settlement charge that management flagged as possible in October but never quantified.

The unambiguous scorecard is the full year measured against the company's own guidance, which is not in dispute.

Year-over-Year Comparison

The Q4 2024 comparative is not usable as an operating benchmark. It absorbed a classified program reach-forward loss at Missiles and Fire Control that drove that segment to a negative $804M operating profit, plus classified charges at Aeronautics. Consolidated segment margin in the base quarter was 2.3%. Every Q4 growth rate below is therefore an artifact of the comparison, and we read the sequential and full-year tables instead.

Sequential Comparison

Full Year 2025

Quarterly sales sum to the full year exactly: $17,963M + $18,155M + $18,609M + $20,321M = $75,048M.

Assessment: revenue. A 5.6% full-year outcome against a mid-single-digit ambition is exactly what this business should deliver, and the composition improved through the year as Missiles and Fire Control ended at +14% and Space at +4%. The more useful datapoint is Q4's $20,321M, a quarterly run rate $2,358M above the $17,963M with which the year opened. Aeronautics supplied $1,268M of the $1,712M sequential step-up, or 74% of it, which is a reminder that the F-35 franchise still sets the company's quarterly shape even when its growth rate does not. The 2026 guide of approximately 5% growth sits well below that annualised exit rate, which is the company declining to extrapolate its strongest quarter.

Assessment: margins. The reported full-year segment margin of 9.0% is meaningless without adjustment, and the adjusted picture is materially better: management disclosed Aeronautics at 9.9% excluding classified losses versus 6.9% reported, and RMS at 11.3% excluding the helicopter charges versus 7.6% reported. Adding back the $1,615M of program losses, clean 2025 segment margin was 11.14%. That is the number to carry forward, and it is why the 2026 guide of 10.86% reads as a step down rather than the expansion the headline implies.

Assessment: EPS. Full-year EPS of $21.49 fell 3.7% in a year when sales rose 5.6% and segment profit rose 10.9%. Management named the culprits precisely: higher interest expense, a higher tax rate, and higher operating FAS/CAS pension expense. This is the third consecutive quarter in which below-the-line items have consumed the operating improvement, and it remains the defining feature of Lockheed's earnings algorithm. What changed this quarter is that one of the three, pension, has now been structurally addressed rather than merely explained.

Segment Performance

Backlog by Segment

Last quarter we flagged that the consolidated record concealed a $15.3B year-to-date drawdown at Aeronautics, and that it would reverse in Q4 when the F-35 Lot 18/19 definitization landed. It did, decisively.

Assessment. Backlog closed at 2.58x full-year sales, its fourth consecutive annual increase, on a 1.2x full-year book-to-bill with more than $65B of orders recorded in the second half alone. Aeronautics rebuilt $11.9B in a single quarter on the Lot 18/19 definitization and the FY26 air vehicle sustainment award, but still finished the year $3.3B lower than it began, which is the honest measure of how fast the F-35 franchise burns its own book. The durable change is at RMS and MFC, which added $17.5B between them for the year. What backlog cannot tell you, and what the 2026 guide now makes explicit, is what it costs to convert.

Missiles and Fire Control — the franchise gets a seven-year contract structure

MFC grew Q4 sales 17.8% to $4,020M on roughly $380M of precision fires production ramp and roughly $180M of PAC-3, closing the year at $14,450M and a 13.8% margin, the best in the portfolio. Q4 operating profit of $535M compares to a negative $804M a year ago, a $1,339M swing that is almost entirely the absence of the prior-year classified reach-forward loss rather than operating improvement.

The structural news came in January rather than in the quarter. Lockheed signed a seven-year framework agreement for PAC-3 MSE and announced a similar framework for THAAD on the morning of the call. The PAC-3 agreement lifts annual production capacity from approximately 600 to 2,000 interceptors, a 3.3x increase, against 120 delivered in 2025.

"As the first implementation of such a long-term multiyear agreement, the PAC-3 MSC will increase annual production capacity from approximately 600 to 2,000 per year."
— James Taiclet, Chairman, President and Chief Executive Officer

Management guided MFC to 14% sales growth in 2026 with margins consistent with 2025, and committed to a sales CAGR of at least double-digit through the end of the decade. It also put a ceiling on the ramp dilution.

"What that would mean for MFC margins in the coming years is some possible dilution, but probably no more than 20 to 30 basis points at max."
— Evan Scott, Chief Financial Officer

Assessment: This is the most important development of the year for the investment case, and it is worth more than the quarter's numbers. A seven-year committed framework with a defined capacity target changes MFC from a business that wins annual lots to one that can plan, tool and hire against a decade. The 20 to 30bps dilution ceiling is a specific, checkable commitment. Our reservation is that the capacity target requires the multibillion-dollar facilities investment now showing up in the capex line, so the shareholder does not get the growth for free.

Aeronautics — the classified program stays quiet, adjusted margin tells the real story

Q4 sales rose 6.4% to $8,524M on roughly $300M of higher classified sales (reflecting the absence of 2024 losses) and roughly $200M of F-35 volume. Adjusted for the prior-year classified charges and C-5 claim resolution, management put adjusted sales growth at approximately 4% and adjusted operating profit as up slightly. Full-year deliveries reached 191 F-35 aircraft, a record and above the 175 to 190 guidance.

Full-year reported margin of 6.9% is the charge-depressed figure; adjusted for the classified losses it was 9.9%. On the program itself, the disclosure was a clean repeat of last quarter.

"However, to note, there were no additional charges reported on this program in the fourth quarter, and we continue to proactively monitor and manage potential risks with our highest level of executives personally involved in this now."
— James Taiclet, Chairman, President and Chief Executive Officer

Management was explicit that the risk is not retired, describing continuing exposure over the next few years as the program progresses through further key phases. For 2026, Aeronautics guides to low-single-digit growth at a 9.8% midpoint margin, with the dilution attributed to growth in Skunk Works and F-35 sustainment.

Assessment: Two consecutive clean quarters on the classified program is the single best piece of news in our thesis, and it converts a bear point from escalating to contained. But guiding 2026 Aero margin to 9.8% against a 9.9% adjusted 2025 means the segment is not expected to improve at all next year, and the reason given is that its growth is coming from lower-margin sustainment and development work. Aeronautics is roughly 40% of the company and it is guided to be flat on margin and low-single-digit on sales.

Rotary and Mission Systems — the recovery that guidance does not extend

RMS grew Q4 sales 8.3% to $4,616M on roughly $225M from Integrated Warfare Systems and Sensors and roughly $145M from Sikorsky, closing a year in which sales were essentially flat at $17,312M. Q4 operating profit fell 8.8% to $468M on unfavourable Black Hawk profit adjustments and the absence of a 2024 intellectual property licence benefit. Full-year adjusted margin, excluding the Canadian Maritime and Turkish Utility helicopter charges, was 11.3% against 7.6% reported, and adjusted operating profit grew 3%.

Guidance for 2026 is low-single-digit sales growth at a 10.5% midpoint margin, with Sikorsky's CH-53K and Black Hawk driving the growth and radar and training program lifecycles offsetting.

Assessment: The $500M in-year revenue cut we flagged in October appears to have been timing rather than permanent loss, since Q4 delivered 8.3% growth and the segment finished flat for the year. But unfavourable Black Hawk profit adjustments in Q4 are the third consecutive quarter with negative rotorcraft news, and guiding 2026 margin to 10.5% against an 11.3% adjusted 2025 concedes another 80bps. Sikorsky remains the least convincing part of the portfolio.

Space — the best margin in the portfolio, guided to hold

Space grew Q4 sales 7.5% to $3,161M on roughly $135M from strategic and missile defense and roughly $45M from national security space, but operating profit fell 3.5% to $273M on roughly $20M of lower ULA equity earnings. Q4 margin of 8.6% landed just above the low-8% band management had signalled in October, confirming that the 9.9% posted in Q3 was a favourable-adjustment quarter rather than a run rate. The full year closed at $13,029M and a 10.3% margin, up 10% on operating profit. The Space Development Agency awarded an 18-satellite Tranche 3 Tracking Layer contract with potential value above $1B.

Assessment: Space guides to approximately 5% growth in 2026 at a margin slightly above 10%, including higher ULA equity earnings, which against a 10.3% full-year 2025 margin is flat at best. No segment is guided to expand margin next year, which is the segment-level expression of the clean-basis decline. The strategic and missile defense franchise (fleet ballistic missile, Next Generation Interceptor, hypersonics) is the real engine and the most credible Golden Dome exposure in the portfolio. The quarter's reliance on ULA equity earnings for the swing factor remains an unhelpful source of volatility in an otherwise improving segment.

Key Topics & Management Commentary

Overall Management Tone: Confident and expansionary, a clear shift from October's measured, execution-focused posture. Where the Q3 call deferred every forward question to January, this call answered them at length and with specificity on capacity targets, contract structures and investment magnitude. The least convincing passage was the handling of the capital-intensity reversal, where the explanation offered was directionally reasonable but did not acknowledge that a commitment made ninety days earlier had been abandoned.

1. Decomposing the 2026 guide: 25% profit growth that is 2% growth

The guidance headline is arresting: sales up approximately 5%, reported segment operating profit up more than 25%, EPS up nearly 39%. The base is the problem. Reported 2025 segment operating profit of $6,743M absorbed $1,615M of program losses recognised in Q2. Adding those back gives a clean 2025 base of $8,358M, against which the 2026 midpoint of $8,550M represents 2.3% growth. On margin, clean 2025 was 11.14% and the 2026 guide implies 10.86%, a 28bps decline.

Management effectively conceded the point in its own EPS bridge.

"The midpoint range is over $8 higher than 2025, primarily due to the aforementioned program pension-related charges accounting for approximately $7 of the year-over-year improvement."
— Evan Scott, Chief Financial Officer

Applying the same normalisation to EPS, the 2025 charges totalled $7.02 per share ($3.04 classified Aeronautics, $1.83 Canadian Maritime, $0.30 Turkish Utility, $0.22 fixed asset write-off, $1.63 pension settlement), putting clean 2025 EPS at $28.51. The 2026 midpoint of $29.80 is 4.5% above that.

Assessment: This is the most consequential analytical point in the release and it is almost entirely absent from the headline framing. Lockheed is guiding 2026 to roughly 5% revenue growth, 2% clean profit growth and slightly lower clean margin. That is a normalisation year, not an inflection year. The company is not misleading anyone (the bridge was disclosed on the call) but the reported growth rates are not the ones an investor should underwrite.

2. Capital intensity: a commitment reversed in ninety days

On the October call the CEO was asked directly whether the combination of capacity expansion and corporate-funded prototyping implied a structurally higher investment burden, and said the company was "not intending to step up the percentages of revenue on either case." The 2026 guide does exactly that. Capex guides to $2,500M to $2,800M against $1,649M spent in 2025, a 61% increase at the midpoint that lifts capex from 2.2% to 3.4% of sales. Capex and independent R&D together approach $5B, up about 35% from roughly $3.5B.

"Free cash flow is anticipated to be in the range of $6.5 to $6.8 billion, which is well above our prior expectation and includes a year-over-year increase in investment of about 35%, with capital and independent research and development approaching $5 billion in 2026, which is a step function increase in internal investment."
— James Taiclet, Chairman, President and Chief Executive Officer

The stated justification is a changed opportunity set: long-term contract structures that make returns predictable enough to underwrite, and a customer newly willing to fund advanced technology development.

Assessment: On the merits the decision is probably right. Spending $2.65B of capex against a $46.7B MFC backlog and a contracted 3.3x capacity increase is a better use of capital than buying back stock at 21x. What concerns us is the disclosure quality: a specific, unprompted commitment made in October was reversed in January without being named as such, and the reversal was surfaced by an analyst rather than by management. That matters for how much weight we give the next forward commitment, including the 20 to 30bps MFC dilution ceiling.

3. The pension is resolved, and better than guided

Three of the six commitments we were tracking from October concerned pension, and all three resolved favourably. The annuity conversion happened in December, transferring $943M of gross obligations to insurers at a $479M pre-tax cost ($377M after tax, $1.63 per share). The company then made an $860M discretionary contribution which, rather than pre-funding "a portion" of the 2026 requirement as guided, fulfilled it entirely.

"What that meant in 2025, of course, is that we had the ability to prefund the required 2026 pension in full such that there's no required this year to your question."
— Evan Scott, Chief Financial Officer

Management flagged that the requirement returns in 2027 at at least $1B, and said it may pre-fund that too if 2026 cash allows.

Assessment: This is a clean win and it retires the sharpest edge of last quarter's bear case. Removing $943M of obligations from the balance sheet and eliminating the 2026 cash call for a one-time $479M non-cash charge is good capital management. The residual issue is that 2027 brings the requirement back, so the pension has been deferred and de-risked rather than eliminated, and the improvement is not permanent.

4. Cash: 2025 beat, 2026 guided lower

Free cash flow of $6,908M exceeded the $6,600M point estimate by $308M and grew 30.7% over 2024, with cash from operations up 22.7% to $8,557M. Management attributed the improvement to working capital conversion and milestone-triggered collections. Against that, 2026 guides free cash flow to $6,500M to $6,800M, a 3.7% decline at the midpoint, entirely because cash from operations growth of 8.7% is more than absorbed by the 61% capex increase.

Assessment: This is the condition we set in October for an upgrade, and it was not met. The nuance matters, though: 2025's $6,908M included an $860M pension contribution that 2026 does not carry, so on a like-for-like operating basis the underlying cash generation is improving meaningfully. The reported decline is a capital allocation choice, not a deterioration. We still decline to upgrade on it, because a choice to spend is only vindicated by the returns it produces, and those are 2027 and 2028 events.

5. Framework agreements with make-whole protection

The seven-year PAC-3 and THAAD frameworks carry a provision that materially changes the risk profile of the munitions ramp. If the government alters its procurement strategy mid-term, Lockheed is made whole.

"But in our agreements, we had ensured with the department, as I alluded to earlier, that if there is a change in the procurement strategy along the way during the seven years, there are make-whole provisions that will bring our company back to sort of the same ROI cash flow perspective as we would normally have had in a single-year appropriation."
— James Taiclet, Chairman, President and Chief Executive Officer

Management also noted that Congress has already advanced seven-year authorisation for four or five specific missile systems including THAAD and PAC-3, and that definitization still requires appropriations, expected during 2026.

Assessment: The make-whole provision is the single most underappreciated disclosure on the call. The historical objection to defense capacity investment is that annual appropriations can collapse demand after the capital is sunk, which is exactly what happened to the munitions industrial base in the mid-2010s. A contractual remedy transfers that risk to the customer. It is not a guarantee (the agreements are frameworks awaiting definitization and appropriation) but it is a structural improvement to the downside case for the capex now being committed.

6. The self-funded prototype portfolio widens

The corporate-level independent R&D reallocation described in October now has named programs attached: an autonomous Black Hawk demonstrated in flight and remotely piloted by the Secretary of War in November, a low-cost cruise missile design called COMET, a collaborative combat aircraft drone wingman demonstrated under F-22 control, a space-based interceptor targeted to fly in 2028, and the X-59 quiet supersonic aircraft flown with NASA in October.

"So we are doing this on our own R&D budget. Another example is the COMET, which is a low-cost, high-capability cruise missile design that we're creating ourselves because we do think there's gonna be upside opportunity in that arena as the cost per unit will be attractive."
— James Taiclet, Chairman, President and Chief Executive Officer

Separately, the company committed an additional $1B of internal investment to F-35 sustainment, specifically spare parts and repair capacity, which management attributed to underfunding in prior defense budgets and framed as an effort to lift fleet mission-capable rates.

Assessment: The portfolio is coherent and the demonstrations are real hardware rather than concepts, which is the correct response to a procurement environment rewarding demonstrated capability. But every item on that list is a cost today against an unfunded revenue hope, and the $1B F-35 sustainment commitment is explicitly spending to remedy a customer's under-budgeting. Management argues the financial return will follow. That is an assertion, and it is being made with shareholder cash at a moment when free cash flow is guided down.

7. Capital returns policy became deliberately ambiguous

Lockheed has returned roughly 100% of free cash flow to shareholders for years, including $3,000M of repurchases and $3,131M of dividends in 2025. Asked twice whether that continues, management declined to commit to either the buyback or the dividend trajectory.

"So we will be evaluating all of our capital deployment options as time progresses. We'll announce those decisions as they occur, publicly as required and has been our practice."
— James Taiclet, Chairman, President and Chief Executive Officer

The CEO also flagged merger and acquisition optionality, noting the company had attempted deals over the past five years including one blocked by a prior administration, and said it would "keep our powder dry" for such opportunities.

Assessment: Refusing to reaffirm the return-of-capital framework in the same call that raises capex 61% is a meaningful signal, and shareholders should read it as one. The arithmetic explains the caution rather than forcing it: a $6,650M free cash flow midpoint less $3.1B of dividends leaves roughly $3.5B, enough to sustain the $3.0B repurchase run rate but not enough to also absorb an acquisition or a further capex step-up. Management is preserving the flexibility to choose, and choosing not to say.

8. The 2026 fiscal calendar distorts the quarterly path

An easily-missed disclosure with real modelling consequences: 2026 has twelve weeks in the first quarter and fourteen in the fourth, against thirteen in every quarter of 2024 and 2025. Q2 and Q3 remain at thirteen.

Assessment: A twelve-week Q1 is roughly 8% fewer operating days than a normal quarter, which will make Q1 2026 look materially weaker than the underlying business, and Q4 correspondingly stronger. Anyone reading the April print without adjusting for this will draw the wrong conclusion. Management disclosed it clearly and once; we expect it to be widely forgotten by April.

9. Budget environment and program positioning

The FY26 appropriations process was still unfolding at the time of the call. Management reported continued broad support across the administration, the Department of War and Congress, and pointed to the core program set (PAC-3, F-35, CH-53K, fleet ballistic missile) as fundamental to stated defense priorities. Management also referenced operational use of F-35, F-22, RQ-170 and Black Hawk platforms in a recent military operation.

Assessment: Combat employment of the platform portfolio is a demand signal that does not appear in any financial statement, and it tends to precede replenishment orders and allied procurement decisions. Combined with the seven-year authorisation advancing for specific missile systems, the appropriations risk that historically capped defense multiples is genuinely lower than it was a year ago. We regard this as a real, if unquantifiable, improvement to the medium-term revenue case.

Guidance & Outlook

Segment-level 2026 guidance runs as follows. Aeronautics grows low-single-digit at a 9.8% midpoint margin, with Skunk Works and F-35 sustainment each capable of double-digit growth and the F-35 production rate holding at 156 aircraft per year. Missiles and Fire Control grows 14% with margins consistent with 2025's 13.8%. Rotary and Mission Systems grows low-single-digit at a 10.5% midpoint margin. Space grows approximately 5% at a margin slightly above 10%, helped by higher ULA equity earnings.

Implied composition: Of the $3,702M of incremental 2026 sales at the midpoint, Missiles and Fire Control contributes roughly $2,020M on its 14% guide, or 55% of the company's entire growth from a segment that is 19% of revenue. The other three segments, representing 81% of the business, are collectively guided to grow low-single-digit. This is a single-engine year.

Street at: There was no 2026 consensus anchor of consequence entering the print, since management had declined to provide directional colour in October. The guide is the anchor.

Guidance style: Consistent with the pattern we described in October. Lockheed guides to achievable ranges and beat every 2025 line, which lends credibility to the 2026 set. The change in style worth noting is the width: a $2,500M sales range and a $0.90 EPS range are both wider than the company carried into 2025, which is appropriate given that PAC-3 and THAAD definitization, and therefore some of the year's revenue, still depends on an appropriations process that had not concluded.

Analyst Q&A Highlights

Whether the capital-intensity commitment from the prior call still stands

The sharpest exchange of the call put management's own October statement against the January release. The question noted that the CEO had previously seen no need for capex and R&D as a percentage of sales to rise materially, and asked what specifically changed. The answer located the change entirely on the customer side.

Q: "Jim, on last quarter's call, I think we talked about R&D and CapEx as a percent of sales. And at the time, you didn't see a need for that to rise materially. But, obviously, that's changed here in the release. I think I understand the CapEx side for a capacity build-out, but what changed specifically in terms of opportunity set?"
— Myles Walton, Wolfe Research

A: "So what's changed, Myles, is the department's very transparent interest in advanced technology development and to support advanced technology development."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: The explanation is plausible and the underlying decision is defensible, but the answer never acknowledged that a specific commitment had been reversed within a single quarter, and the question of whether the new levels are the norm or a floor went unanswered. We now treat forward commitments from this management team as directional guidance rather than constraints, which lowers the weight we assign to the MFC dilution ceiling offered later on the same call.

Whether returning roughly all free cash flow to shareholders survives the capex step-up

The opening question went straight to the capital allocation consequence of the investment increase, asking whether the long-standing practice of returning approximately 100% of free cash flow was being abandoned. Management reframed rather than answered, describing a process that is unchanged while the conditions it operates on have shifted, and adding merger and acquisition optionality to the list of competing uses.

Q: "You have the big step up in CapEx for this year, and it seems like that's gonna persist for the next few years. So are you changing your overall capital deployment strategy of returning 100% free cash flow to shareholders following the president's executive orders? And if so, should investors expect that to be a new normal?"
— Scott Micas, Melius Research

A: "So the process remains the same, but the conditions have changed. On the availability of accretive investments that we can make in our company."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: A non-answer that is itself the answer. Management would have reaffirmed the framework if it intended to maintain it. Combined with the refusal later in the call to commit to the buyback or dividend trajectory, the reasonable base case is that repurchases moderate materially in 2026 to fund capex without further debt issuance. Given the share count has been supplying most of Lockheed's EPS growth, that is a direct headwind to reported earnings from 2027.

Appropriations risk across a seven-year munitions ramp

A pointed historical question raised the mid-2010s precedent, when surging missile demand collapsed and stranded industrial capacity, and asked how the company gets comfortable underwriting a seven-year ramp against annual appropriations. The answer produced the call's most substantive new disclosure: a contractual make-whole remedy.

Q: "And there are periods of time, and you all saw this back kind of in the 2015 time frame when there was huge growing demand for missiles. And then things changed, and that all collapsed. And so how do you get comfortable about that seven-year ramp that the support will be there?"
— Douglas Harned, Bernstein

A: "So there is a remediation element to and a strong remediation element to make whole if the procurement strategy changes."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: The best answer of the call, and one that changes the analysis. If the make-whole provisions survive definitization, the downside case for the munitions capex shifts from stranded capacity to a contractual claim. The caveat is that the frameworks are not yet definitized contracts and the remedy has never been tested. We give it partial credit: enough to reduce the risk premium on the capex, not enough to underwrite the capacity target.

Multi-year framework timing and the margin path at Missiles and Fire Control

A two-part question sought the definitization timeline for the PAC-3 and THAAD frameworks and the long-term margin consequence of a seven-year production structure. Management put definitization inside 2026 subject to appropriations, and then volunteered an unusually specific dilution ceiling alongside a claim that the structure ultimately lifts margins above historical levels.

Q: "First, regarding the two missile framework deals for PAC-3 and THAAD, what's the timing of a multiyear there? And how are you thinking about MFC margin potential, you know, over the long term?"
— Richard Safran, Seaport Research Partners

A: "So think of this as a seven-year program that will step up over time. What that would mean for MFC margins in the coming years is some possible dilution, but probably no more than 20 to 30 basis points at max."
— Evan Scott, Chief Financial Officer

Assessment: A quantified, falsifiable commitment, which is what we want and rarely get. The logic is standard percentage-of-completion behaviour: book conservatively early, release profit as risk retires. The tension is that the same call reversed a commitment made ninety days earlier, so we hold this one loosely. If MFC margin holds within 30bps of 13.8% through the ramp, it is powerful evidence for the bull case.

The classified Aeronautics program and the 2027 pension requirement

A combined question sought a status update on the program that produced the year's largest charge and clarity on when the pension cash call returns. Management characterised the classified program as progressing well while explicitly declining to declare the risk retired, and confirmed the 2027 requirement returns at at least $1B with the possibility of pre-funding it early.

Q: "I was wondering if you could give us a quick refresher on how the Aero classified program is performing. And also, Evan, if you could just speak to 2027 pension requirements given where things sit today."
— Gautam Khanna, TD Cowen

A: "As a reminder, this is a very complex design and system integration activity. And risk is gonna remain over the next few years as we progress through, you know, more key phases of the program, which is progressing well."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: Consistent with October and appropriately hedged. Two clean quarters plus monthly executive-level monitoring is real progress, but management is telling you directly that further phases carry risk over the next few years. We keep this bear point live rather than closing it, and note that the same program has already demonstrated it can absorb $950M in a single quarter.

Whether the multiyear frameworks bring cash support alongside the capital requirement

A useful clarification asked whether operating cash flow guidance embeds any customer support or capital reimbursement associated with the ramp. Management confirmed that favourable cash terms are a deliberate feature of the framework design, intended to offset part of the capital outlay, and separately described a profit-sharing mechanism above a defined performance threshold.

Q: "Quick clarification on cash flow first. Is there any customer support or CapEx reimbursement in your operating cash flow? And then on the PAC-3 and THAAD frameworks, could you talk a little bit more about how those are structured, maybe particularly as it relates to kind of the performance opportunity versus risk?"
— Gavin Parsons, UBS

A: "So I think you are going to see an elevated working capital benefit or operational benefit to offset some of these CapEx expenditures. So that is a key part of what we're contemplating with these deals."
— Evan Scott, Chief Financial Officer

Assessment: This materially softens the capex concern and it is the reason cash from operations grows 8.7% in 2026 despite only 4.9% sales growth. The customer is partly financing the capacity it is demanding. The profit-sharing structure above a threshold caps the upside in exchange, with the shared portion recycled into spares and tooling rather than returned as margin, which is a reasonable trade but should temper expectations for MFC margin expansion beyond the ramp.

The $1B strategic investment in F-35 sustainment

Asked to unpack the additional billion committed to F-35 sustainment and whether it was directed by the customer, management framed it as remedying several years of under-budgeted spare parts and repair capacity, on top of more than $1B already invested, with the objective of raising fleet mission-capable rates.

Q: "You talked about $1 billion strategic investment on F-35 sustainment. Can you maybe give us a little bit more detail and unpack that, what the expectations are? Was that maybe at the direction of the government?"
— Michael Ciarmoli, Truist Securities

A: "It does require investment, but these systems are so critical in today's world that we do feel that we are gonna get benefit both financially and operationally the performance of the aircraft for making this investment, so we're going to do it."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: Read plainly, the prime is funding a customer's procurement shortfall from its own balance sheet in the expectation of future sustainment economics. That can be a good trade, because sustainment is higher-margin and stickier than production and mission-capable rates drive fleet expansion decisions. But it is discretionary spending with no contractual return attached, disclosed in the same quarter that free cash flow is guided down, and it deserves to be labelled as what it is.

What They're NOT Saying

1. That the 2026 profit guide is roughly flat on a clean basis. Every headline framing uses the charge-depressed 2025 base. The bridge disclosing that roughly $7 of the $8.31 EPS increase is charge normalisation was given once, in passing, in the prepared remarks. The clean segment profit growth of 2.3% and the 28bps clean margin decline were never stated.
2. Whether the buyback continues. Asked twice, management declined to commit to either the repurchase pace or the dividend trajectory. A $6,650M free cash flow midpoint less $3.1B of dividends leaves roughly $3.5B, so the $3.0B repurchase run rate is fundable, with about $519M to spare. Management declining to confirm it anyway is the signal.
3. Whether 2026 capex is the peak or a step to a higher plateau. The question was asked directly and the answer addressed why investment rose, not where it settles. Management said only that investment "will continue to be elevated going forward," which is not a number and not a duration.
4. The size of the multibillion-dollar munitions investment. A three-year program across facilities in five states was announced without a total. The 2026 guide includes only "the initial portion." Shareholders are being asked to accept an unbounded commitment on a program whose contracts are not yet definitized.
5. What the classified Aeronautics program's remaining exposure is. Management confirmed risk remains "over the next few years" through further key phases without sizing the remaining fixed-price content or the phases still to come. Two clean quarters is progress; a ceiling would be disclosure.
6. Why Aeronautics margin is guided flat and RMS margin down. The 2026 guide puts Aero at 9.8% against a 9.9% adjusted 2025 and RMS at 10.5% against 11.3% adjusted. Together those segments are 63% of revenue. The mix explanations offered (Skunk Works, sustainment, program lifecycles) describe the direction without quantifying how much is permanent mix shift versus temporary.
7. Any 2027 framework. Asked directly about the long-term growth and margin model in light of the munitions ramp, management declined to offer multi-year targets, saying only that there is upward pressure on revenue and an intention to drive margins. For a company committing three years of elevated capital, the absence of a return framework is conspicuous.

Market Reaction

• Pre-print setup: LMT closed at $597.27 on January 28, its 52-week closing high, after a 23.5% advance during January alone and 31.5% over the trailing twelve months. The S&P 500 was up 1.9% year to date over the same period, putting LMT roughly 22 points ahead of the index in a single month. The 52-week closing range entering the print was $410.74 to $597.27.
• Reaction session: The stock gapped up 2.0% to open at $609.24, traded as high as $645.67 (+8.1%), and closed at $622.51, up 4.2% or $25.24.
• Volume: 3.9M shares against a 1.8M thirty-day average, 2.2x normal.
• Benchmark: The S&P 500 fell 0.1% on the session, so the entire advance was stock-specific.

The market bought the guide, not the quarter. Reported Q4 EPS was in line and reported net earnings fell 17% sequentially, yet the stock added 4.2% on a session that opened higher and briefly traded up more than 8%. What was being priced is the 2026 revenue and profit guidance, the record backlog, and the pension resolution, in roughly that order. The fade from the $645.67 intraday high back to $622.51 is the part worth attention: something in the detail cooled the initial enthusiasm, and the capex line and the refusal to reaffirm the buyback are the two candidates.

The setup deserves as much weight as the reaction. Three months ago LMT was a relative laggard trading at $489.50, down 17.7% over twelve months and ten points behind the index year to date. It enters February at $622.51, up 27.2% since our initiation and 31.5% over twelve months. Much of that move happened in January, before the print, coinciding with the PAC-3 framework announcement. A stock that has re-rated this hard into a guide has already priced the good news, and the 4.2% add on a quarter whose reported earnings declined is evidence of how much benefit of the doubt is now embedded.

Street Perspective

Debate: Is the 2026 guide an inflection or a normalisation?

Bull view: The bull case being made on the Street is that 2026 marks the year the demand cycle finally reaches the income statement: sales up 5%, reported segment profit up more than 25%, EPS up nearly 39%, on a record backlog with seven-year contract structures behind the fastest-growing segment. The multiple has compressed to roughly 21x on a guided number that management has a demonstrated record of beating.

Bear view: The bear camp contends the growth is arithmetic. Strip the $1,615M of 2025 program losses and segment profit grows 2.3% with margin 28bps lower, and management's own EPS bridge attributes roughly $7 of the $8.31 increase to charge and pension normalisation. Three of four segments are guided to low-single-digit growth with flat-to-lower margins.

Our take: The bear framing is arithmetically correct and it is the frame we use. This is a normalisation year with one genuine growth engine, and investors underwriting 26% profit growth are underwriting a base effect. That said, the bulls are right that a normalisation year is not a bad year: clean margin holding near 11% while absorbing a 61% capex increase and a munitions ramp is a respectable outcome. The disagreement is about what multiple a 4.5% clean earnings grower deserves, and 21x is not obviously the answer.

Debate: Does the capex step-up create value or consume it?

Bull view: The bull case is that Lockheed is being handed an unusual opportunity: seven-year committed frameworks with make-whole protection and customer cash support, against a contracted 3.3x capacity increase in its highest-margin product. Investing $2.65B into that is a demonstrably better use of capital than repurchasing stock at 21x, and the returns arrive in 2027 and 2028.

Bear view: The bear camp contends that a company reversing a capital-intensity commitment within one quarter, declining to say where investment settles, refusing to size a multibillion-dollar three-year program, and simultaneously going quiet on the buyback has lost the discipline that made it a defensive holding. Free cash flow is guided down, the share count shrink that supplied most of the EPS growth is now at risk, and none of the promised return has a contract attached.

Our take: On the economics the bulls have it, and the make-whole and working-capital provisions materially de-risk the investment. On the governance the bears have it, and the reversal-without-acknowledgement is a genuine mark against the disclosure record. Our resolution is to accept the spending as sound while declining to pay for its returns before they appear. That is precisely a Hold.

Debate: Is 21x justified after a 27% three-month move?

Bull view: At roughly 20.9x the 2026 midpoint, LMT is cheaper on forward earnings than it was three months ago at $489.50, because the guide rose faster than the price. A 2.2% dividend with a 23-year growth record, a 2.58x backlog-to-sales ratio, and a resolved pension support a re-rating toward the broader market multiple.

Bear view: The bear camp contends that the forward multiple compressed only because the denominator absorbed a charge recovery. On clean 2025 earnings of $28.51, the stock has re-rated from roughly 17x to 21.8x in three months for a business guiding 4.5% clean growth. The free cash flow yield has fallen from 5.8% to 4.6%, which is the more honest measure for a capital-intensive business now spending 3.4% of sales on capex.

Our take: The bears win this one on measurement. Comparing $622.51 against clean 2025 EPS of $28.51 gives 21.8x, and the free cash flow yield compression from 5.8% to 4.6% is the cleanest statement of what the market did in three months. Applying 20x to 22x to the $29.80 guided midpoint gives a fair value range of $596 to $656, with the midpoint of $626 implying roughly 1% upside. The stock is fairly valued on a guide it should meet.

Model Update Needed

Valuation: We raise our fair value range to $596 to $656 from $495 to $550, on a multiple expanded to 20x to 22x from 18x to 20x and applied to a materially higher $29.80 FY2026 EPS estimate. The midpoint of $626 implies roughly 1% upside from the $622.51 close. The multiple expansion is earned: the pension is resolved, two consecutive quarters have been clean, and the framework agreements carry make-whole protection, which collectively lower the variance we were discounting in October. Working against it are flat free cash flow, capital intensity 117bps higher as a share of sales, and an unconfirmed return-of-capital framework, which is why we stop at 22x rather than going further.

Thesis Scorecard Post-Earnings

Scored against the standing thesis established at initiation in October, with status tags carried forward.

Overall: The thesis is better than it was and the stock is more expensive than it was. Two of three bear points improved to contained, which is real progress against the risks that drove our initiation. What replaced them is a new one: the company has chosen to convert its cash advantage into capacity, and it made that choice while reversing a commitment it had given a quarter earlier. The demand pillars are now close to unassailable. The conversion question simply moved from "can they earn it" to "what will it cost to build it."

Action: Maintaining Hold with a fair value range of $596 to $656. In October we set two conditions for an upgrade: two consecutive quarters without a program charge, and a January guide showing free cash flow growth after the pension contribution. The first was met and the second was not, so the rating stands. We would move to Outperform on evidence that the capex is converting, specifically MFC margin holding within 30bps of 13.8% through the ramp alongside a reaffirmed capital return framework, or on a price below $560. We would move to Underperform on a new fixed-price development charge, on MFC margin dilution exceeding the 30bps management committed to, or on 2027 capex guidance above 3.5% of sales without a stated return framework.